The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute

Kazunori Tsukuda, Ryuji Hirai, Takayoshi Miyake, Shoji Takagi, Eiji Ikeda, Tadayoshi Kunitomo, Hisashi Tsuji

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract arising from Cajal's cells and expressing c-kit. In a consensus report, the clinical behavior of GISTs was categorized into risk classes according to the tumor size and mitotic count. We analyzed the risk categories based on GIST patients who underwent a surgical resection at our institute during a period of 15 years. Methods. We evaluated the risk categories of GISTs and analyzed the outcome and risk categories retrospectively. We presented the MIB-1 score of the tumor instead of mitotic counts for the evaluation of cellular growth because of inaccuracies regarding the mitotic counts. Results. Patients were classified into 4 cases of very low risk, 11 of low risk, 8 of intermediate risk, and 5 of high risk. Four high-risk patients showed recurrence as either liver metastasis or peritoneal dissemination. In addition, local recurrence occurred in one low-risk and one intermediate-risk patient each. Conclusion. Our cases confirmed the correlation between the risk categories and the prognosis. A complete resection with sufficient margin must be confirmed even in low-risk cases to prevent local recurrence. Since high-risk patients showed poor prognosis, the adjuvant treatment with chemotherapeutic regimens must therefore be further studied for high-risk patients.

Original languageEnglish
Pages (from-to)953-957
Number of pages5
JournalSurgery Today
Volume37
Issue number11
DOIs
Publication statusPublished - Nov 2007

Fingerprint

Gastrointestinal Stromal Tumors
Recurrence
Neoplasms

Keywords

  • Gastrointestinal stromal tumor
  • MIB-1 index
  • Risk category

ASJC Scopus subject areas

  • Surgery

Cite this

Tsukuda, K., Hirai, R., Miyake, T., Takagi, S., Ikeda, E., Kunitomo, T., & Tsuji, H. (2007). The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute. Surgery Today, 37(11), 953-957. https://doi.org/10.1007/s00595-007-3535-3

The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute. / Tsukuda, Kazunori; Hirai, Ryuji; Miyake, Takayoshi; Takagi, Shoji; Ikeda, Eiji; Kunitomo, Tadayoshi; Tsuji, Hisashi.

In: Surgery Today, Vol. 37, No. 11, 11.2007, p. 953-957.

Research output: Contribution to journalArticle

Tsukuda, K, Hirai, R, Miyake, T, Takagi, S, Ikeda, E, Kunitomo, T & Tsuji, H 2007, 'The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute', Surgery Today, vol. 37, no. 11, pp. 953-957. https://doi.org/10.1007/s00595-007-3535-3
Tsukuda, Kazunori ; Hirai, Ryuji ; Miyake, Takayoshi ; Takagi, Shoji ; Ikeda, Eiji ; Kunitomo, Tadayoshi ; Tsuji, Hisashi. / The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute. In: Surgery Today. 2007 ; Vol. 37, No. 11. pp. 953-957.
@article{80ce3835a40645eea69a730556b3d886,
title = "The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute",
abstract = "Purpose. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract arising from Cajal's cells and expressing c-kit. In a consensus report, the clinical behavior of GISTs was categorized into risk classes according to the tumor size and mitotic count. We analyzed the risk categories based on GIST patients who underwent a surgical resection at our institute during a period of 15 years. Methods. We evaluated the risk categories of GISTs and analyzed the outcome and risk categories retrospectively. We presented the MIB-1 score of the tumor instead of mitotic counts for the evaluation of cellular growth because of inaccuracies regarding the mitotic counts. Results. Patients were classified into 4 cases of very low risk, 11 of low risk, 8 of intermediate risk, and 5 of high risk. Four high-risk patients showed recurrence as either liver metastasis or peritoneal dissemination. In addition, local recurrence occurred in one low-risk and one intermediate-risk patient each. Conclusion. Our cases confirmed the correlation between the risk categories and the prognosis. A complete resection with sufficient margin must be confirmed even in low-risk cases to prevent local recurrence. Since high-risk patients showed poor prognosis, the adjuvant treatment with chemotherapeutic regimens must therefore be further studied for high-risk patients.",
keywords = "Gastrointestinal stromal tumor, MIB-1 index, Risk category",
author = "Kazunori Tsukuda and Ryuji Hirai and Takayoshi Miyake and Shoji Takagi and Eiji Ikeda and Tadayoshi Kunitomo and Hisashi Tsuji",
year = "2007",
month = "11",
doi = "10.1007/s00595-007-3535-3",
language = "English",
volume = "37",
pages = "953--957",
journal = "Japanese Journal of Surgery",
issn = "0941-1291",
publisher = "Springer Japan",
number = "11",

}

TY - JOUR

T1 - The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute

AU - Tsukuda, Kazunori

AU - Hirai, Ryuji

AU - Miyake, Takayoshi

AU - Takagi, Shoji

AU - Ikeda, Eiji

AU - Kunitomo, Tadayoshi

AU - Tsuji, Hisashi

PY - 2007/11

Y1 - 2007/11

N2 - Purpose. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract arising from Cajal's cells and expressing c-kit. In a consensus report, the clinical behavior of GISTs was categorized into risk classes according to the tumor size and mitotic count. We analyzed the risk categories based on GIST patients who underwent a surgical resection at our institute during a period of 15 years. Methods. We evaluated the risk categories of GISTs and analyzed the outcome and risk categories retrospectively. We presented the MIB-1 score of the tumor instead of mitotic counts for the evaluation of cellular growth because of inaccuracies regarding the mitotic counts. Results. Patients were classified into 4 cases of very low risk, 11 of low risk, 8 of intermediate risk, and 5 of high risk. Four high-risk patients showed recurrence as either liver metastasis or peritoneal dissemination. In addition, local recurrence occurred in one low-risk and one intermediate-risk patient each. Conclusion. Our cases confirmed the correlation between the risk categories and the prognosis. A complete resection with sufficient margin must be confirmed even in low-risk cases to prevent local recurrence. Since high-risk patients showed poor prognosis, the adjuvant treatment with chemotherapeutic regimens must therefore be further studied for high-risk patients.

AB - Purpose. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract arising from Cajal's cells and expressing c-kit. In a consensus report, the clinical behavior of GISTs was categorized into risk classes according to the tumor size and mitotic count. We analyzed the risk categories based on GIST patients who underwent a surgical resection at our institute during a period of 15 years. Methods. We evaluated the risk categories of GISTs and analyzed the outcome and risk categories retrospectively. We presented the MIB-1 score of the tumor instead of mitotic counts for the evaluation of cellular growth because of inaccuracies regarding the mitotic counts. Results. Patients were classified into 4 cases of very low risk, 11 of low risk, 8 of intermediate risk, and 5 of high risk. Four high-risk patients showed recurrence as either liver metastasis or peritoneal dissemination. In addition, local recurrence occurred in one low-risk and one intermediate-risk patient each. Conclusion. Our cases confirmed the correlation between the risk categories and the prognosis. A complete resection with sufficient margin must be confirmed even in low-risk cases to prevent local recurrence. Since high-risk patients showed poor prognosis, the adjuvant treatment with chemotherapeutic regimens must therefore be further studied for high-risk patients.

KW - Gastrointestinal stromal tumor

KW - MIB-1 index

KW - Risk category

UR - http://www.scopus.com/inward/record.url?scp=35448964759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448964759&partnerID=8YFLogxK

U2 - 10.1007/s00595-007-3535-3

DO - 10.1007/s00595-007-3535-3

M3 - Article

VL - 37

SP - 953

EP - 957

JO - Japanese Journal of Surgery

JF - Japanese Journal of Surgery

SN - 0941-1291

IS - 11

ER -